Literature DB >> 8411284

Nitric oxide production is inhibited in trauma patients.

T D Jacob1, J B Ochoa, A O Udekwu, J Wilkinson, T Murray, T R Billiar, R L Simmons, D W Marion, A B Peitzman.   

Abstract

Elevated levels of nitrates/nitrites, the stable endproducts of nitric oxide (NO), were recently observed in septic patients. In this setting, NO maintains blood flow by vasodilation and inhibition of platelet aggregation. Trauma patients were found to have low plasma levels of nitrates/nitrites, even when they developed sepsis. The current study substantiated that trauma patients have suppressed production of NO; reductions in plasma nitrate/nitrite levels correlated with low urinary excretion of these endproducts. Nitric oxide production was upregulated in trauma patients with clinical infection compared with trauma patients without infection, but was still significantly suppressed compared with nitric oxide production in normal controls. The inability of trauma patients to produce NO may be an important component of the susceptibility of these patients to infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411284     DOI: 10.1097/00005373-199310000-00015

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  10 in total

Review 1.  Update on the role of endothelial cells in trauma.

Authors:  J Greven; R Pfeifer; Q Zhi; H C Pape
Journal:  Eur J Trauma Emerg Surg       Date:  2017-07-03       Impact factor: 3.693

2.  A decreased serum concentration of nitrite/nitrate correlates with an increased plasma concentration of lactate during and after major surgery.

Authors:  S Fujioka; K Mizumoto; K Okada
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats.

Authors:  B H Pannen; N Köhler; B Hole; M Bauer; M G Clemens; K K Geiger
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 4.  Signaling and stress: The redox landscape in NOS2 biology.

Authors:  Douglas D Thomas; Julie L Heinecke; Lisa A Ridnour; Robert Y Cheng; Aparna H Kesarwala; Christopher H Switzer; Daniel W McVicar; David D Roberts; Sharon Glynn; Jon M Fukuto; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

5.  Nitric oxide production in critically ill patients.

Authors:  H R Wong; J A Carcillo; G Burckart; S S Kaplan
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

6.  Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis.

Authors:  P H Groeneveld; K M Kwappenberg; J A Langermans; P H Nibbering; L Curtis
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

Review 7.  Molecular mechanisms of pharmaconutrients.

Authors:  Rachel Santora; Rosemary A Kozar
Journal:  J Surg Res       Date:  2009-07-17       Impact factor: 2.192

Review 8.  Update on postinjury nutrition.

Authors:  Samuel R Todd; Ernest A Gonzalez; Krista Turner; Rosemary A Kozar
Journal:  Curr Opin Crit Care       Date:  2008-12       Impact factor: 3.687

Review 9.  Role of nitric oxide in inflammation and tissue injury during endotoxemia and hemorrhagic shock.

Authors:  N S Shah; T R Billiar
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

10.  Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.

Authors:  David J Tate; Derek J Vonderhaar; Yupanqui A Caldas; Toye Metoyer; John R Patterson; Diego H Aviles; Arnold H Zea
Journal:  J Hematol Oncol       Date:  2008-09-25       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.